ICU MedicalICUI
Market Cap: 3.12B
About: ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.
Employees: 14,000
Fund manager confidence
Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)
44% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 70
20% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 30
12% more capital invested
Capital invested by funds: $2.15B [Q4 2023] → $2.4B (+$250M) [Q1 2024]
3.32% more ownership
Funds ownership: 89.11% [Q4 2023] → 92.42% (+3.32%) [Q1 2024]
3% more funds holding
Funds holding: 238 [Q4 2023] → 244 (+6) [Q1 2024]
41% less call options, than puts
Call options by funds: $1.59M | Put options by funds: $2.68M
Research analyst outlook
3 Wall Street Analysts provided 1 year price forecasts over the past 6 months
3 analyst ratings
Raymond James Jayson Bedford | 5%upside $135 | Outperform Upgraded | 17 Jun 2024 |
Keybanc Brett Fishbin | 6%upside $136 | Overweight Maintained | 28 Feb 2024 |
Keybanc Brett Fishbin | 5%upside $134 | Overweight Initiated | 6 Feb 2024 |